CA Stock MarketDetailed Quotes

TBP Tetra Bio Pharma Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayMarket Closed Sep 8 09:30 ET
10.58MMarket Cap-0.31P/E (TTM)

Tetra Bio Pharma Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2022
(Q2)May 31, 2022
(Q1)Feb 28, 2022
(FY)Nov 30, 2021
(Q4)Nov 30, 2021
(Q3)Aug 31, 2021
(Q2)May 31, 2021
(Q1)Feb 28, 2021
(FY)Nov 30, 2020
(Q4)Nov 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
88.43%-873.53K
82.36%-1.92M
37.95%-2.39M
-42.75%-25.28M
50.74%-3M
-117.14%-7.55M
-119.21%-10.87M
-21.29%-3.85M
-38.03%-17.71M
-94.07%-6.09M
Net income from continuing operations
39.56%-3.49M
52.75%-3.72M
80.53%-1.63M
-146.65%-52.18M
-311.71%-30.19M
-19.92%-5.77M
-75.73%-7.86M
-84.30%-8.35M
-61.72%-21.15M
-129.35%-7.33M
Operating gains losses
--0
-61.25%76.37K
-23.50%139.06K
253.60%949.29K
183.01%433.78K
29.89%136.66K
--197.09K
--181.76K
--268.47K
--153.27K
Depreciation and amortization
-17.77%21.94K
-34.08%21.94K
36.19%21.94K
225.57%111.95K
275.49%35.89K
238.11%26.68K
-9.65%33.28K
120.25%16.11K
25.11%34.39K
-65.22%9.56K
Asset impairment expenditure
--0
--474.65K
----
6,115.87%24.63M
--24.63M
--0
--0
----
--396.24K
--0
Unrealized gains and losses of investment securities
165.00%146.25K
--0
66.67%-73.13K
--585K
--365.63K
---225K
--663.75K
---219.38K
----
----
Remuneration paid in stock
-70.12%167.65K
-81.79%122.6K
--152.09K
86.40%1.05M
---179.97K
153.94%561.04K
470.81%673.23K
--0
143.40%565.62K
--0
Other non cashItems
----
----
--111.53K
--111.53K
----
----
----
----
----
----
Change In working capital
205.13%2.39M
124.12%1.1M
-124.73%-1.12M
-124.88%-542.73K
66.29%1.79M
-458.33%-2.28M
-605.74%-4.57M
303.52%4.52M
27,177.21%2.18M
2,976.88%1.07M
-Change in receivables
71.82%425.66K
1,338.20%551.38K
-1,523.84%-2.3M
210.68%397.6K
110.97%32.56K
1,393.09%247.74K
-16.70%-44.53K
3,215.54%161.82K
-177.20%-359.23K
-1,612.69%-296.71K
-Change in prepaid assets
109.18%62.2K
219.22%806.95K
-746.67%-242.77K
-29.22%-380.95K
3,294.20%935.93K
-686.87%-677.56K
-847.92%-676.86K
134.76%37.54K
-193.65%-294.8K
-116.85%-29.3K
-Change in payables and accrued expense
203.18%1.9M
100.47%18.1K
-73.22%1.16M
-119.73%-559.38K
-41.55%818.82K
-349.32%-1.85M
-615.37%-3.85M
250.30%4.32M
459.78%2.84M
706.66%1.4M
-Change in other working capital
----
---273.39K
--273.39K
----
----
----
----
----
----
----
Cash from discontinued investing activities
57.27%-1.93M
-22.64%-2.32M
Operating cash flow
88.43%-873.53K
82.36%-1.92M
37.95%-2.39M
-28.72%-25.28M
64.32%-3M
-150.67%-7.55M
-110.91%-10.87M
-26.12%-3.85M
-13.22%-19.64M
-67.21%-8.41M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
38.01%-2.12M
63.63%-683.75K
81.77%-139.52K
-1,527.72%-790.53K
39.04%-506.23K
7.24%-3.42M
-637.75%-1.88M
Net PPE purchase and sale
--0
--0
--0
-39.09%-336.03K
78.06%-11.25K
22.04%-97.65K
-2.83%-48.71K
-909.15%-178.42K
5.19%-241.58K
79.88%-51.28K
Net intangibles purchas and sale
--0
--0
--0
57.23%-818.5K
98.71%-19.5K
---41.87K
---741.82K
96.15%-15.31K
---1.91M
---1.52M
Net business purchase and sale
--0
--0
--0
23.67%-965.5K
-108.96%-653K
100.00%1
100.00%-1
---312.5K
63.14%-1.26M
---312.5K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
38.01%-2.12M
63.63%-683.75K
81.77%-139.52K
-1,527.72%-790.53K
39.04%-506.23K
7.24%-3.42M
-637.75%-1.88M
Financing cash flow
Cash flow from continuing financing activities
-1,515.74%-378.47K
-100.07%-18.18K
-59.27%1.18M
26.62%29.78M
0
26.73K
166.99%26.87M
-78.54%2.89M
204.34%23.52M
0
Net issuance payments of debt
---378.47K
-1,594.10%-498.13K
-159.48%-574.93K
--1M
--0
--0
--33.34K
--966.66K
----
----
Net common stock issuance
--0
--0
13.00%2.13M
6.72%26.31M
--1.88M
--0
146.31%22.54M
-87.84%1.88M
196.59%24.65M
--0
Proceeds from stock option exercised by employees
--0
-92.82%500K
--0
114.97%5.14M
---1.88M
--26.73K
199.59%6.97M
-46.47%36.4K
697.48%2.39M
--0
Net other financing activities
--0
99.25%-20.05K
---378.42K
24.27%-2.67M
--0
--0
-89.03%-2.67M
----
-298.97%-3.52M
--0
Cash from discontinued financing activities
Financing cash flow
-1,515.74%-378.47K
-100.07%-18.18K
-59.27%1.18M
26.62%29.78M
--0
--26.73K
166.99%26.87M
-78.54%2.89M
141.77%23.52M
--0
Net cash flow
Beginning cash position
-89.31%1.74M
256.92%3.67M
95.38%4.89M
22.72%2.5M
-22.48%8.57M
-1.71%16.24M
-91.41%1.03M
22.72%2.5M
-85.00%2.04M
98.50%11.06M
Current changes in cash
83.66%-1.25M
-112.73%-1.94M
17.47%-1.21M
415.15%2.39M
64.19%-3.69M
-102.88%-7.66M
234.26%15.21M
-114.74%-1.47M
104.10%463.01K
-213.16%-10.29M
End cash Position
-94.36%483.2K
-89.31%1.74M
256.92%3.67M
95.38%4.89M
95.38%4.89M
-22.48%8.57M
-1.71%16.24M
-91.41%1.03M
22.72%2.5M
22.72%2.5M
Free cash from
88.64%-873.53K
83.56%-1.92M
40.92%-2.39M
-21.29%-26.43M
69.62%-3.03M
-145.11%-7.69M
-124.18%-11.66M
-16.62%-4.05M
-23.83%-21.79M
-88.79%-9.98M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2022(Q2)May 31, 2022(Q1)Feb 28, 2022(FY)Nov 30, 2021(Q4)Nov 30, 2021(Q3)Aug 31, 2021(Q2)May 31, 2021(Q1)Feb 28, 2021(FY)Nov 30, 2020(Q4)Nov 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 88.43%-873.53K82.36%-1.92M37.95%-2.39M-42.75%-25.28M50.74%-3M-117.14%-7.55M-119.21%-10.87M-21.29%-3.85M-38.03%-17.71M-94.07%-6.09M
Net income from continuing operations 39.56%-3.49M52.75%-3.72M80.53%-1.63M-146.65%-52.18M-311.71%-30.19M-19.92%-5.77M-75.73%-7.86M-84.30%-8.35M-61.72%-21.15M-129.35%-7.33M
Operating gains losses --0-61.25%76.37K-23.50%139.06K253.60%949.29K183.01%433.78K29.89%136.66K--197.09K--181.76K--268.47K--153.27K
Depreciation and amortization -17.77%21.94K-34.08%21.94K36.19%21.94K225.57%111.95K275.49%35.89K238.11%26.68K-9.65%33.28K120.25%16.11K25.11%34.39K-65.22%9.56K
Asset impairment expenditure --0--474.65K----6,115.87%24.63M--24.63M--0--0------396.24K--0
Unrealized gains and losses of investment securities 165.00%146.25K--066.67%-73.13K--585K--365.63K---225K--663.75K---219.38K--------
Remuneration paid in stock -70.12%167.65K-81.79%122.6K--152.09K86.40%1.05M---179.97K153.94%561.04K470.81%673.23K--0143.40%565.62K--0
Other non cashItems ----------111.53K--111.53K------------------------
Change In working capital 205.13%2.39M124.12%1.1M-124.73%-1.12M-124.88%-542.73K66.29%1.79M-458.33%-2.28M-605.74%-4.57M303.52%4.52M27,177.21%2.18M2,976.88%1.07M
-Change in receivables 71.82%425.66K1,338.20%551.38K-1,523.84%-2.3M210.68%397.6K110.97%32.56K1,393.09%247.74K-16.70%-44.53K3,215.54%161.82K-177.20%-359.23K-1,612.69%-296.71K
-Change in prepaid assets 109.18%62.2K219.22%806.95K-746.67%-242.77K-29.22%-380.95K3,294.20%935.93K-686.87%-677.56K-847.92%-676.86K134.76%37.54K-193.65%-294.8K-116.85%-29.3K
-Change in payables and accrued expense 203.18%1.9M100.47%18.1K-73.22%1.16M-119.73%-559.38K-41.55%818.82K-349.32%-1.85M-615.37%-3.85M250.30%4.32M459.78%2.84M706.66%1.4M
-Change in other working capital -------273.39K--273.39K----------------------------
Cash from discontinued investing activities 57.27%-1.93M-22.64%-2.32M
Operating cash flow 88.43%-873.53K82.36%-1.92M37.95%-2.39M-28.72%-25.28M64.32%-3M-150.67%-7.55M-110.91%-10.87M-26.12%-3.85M-13.22%-19.64M-67.21%-8.41M
Investing cash flow
Cash flow from continuing investing activities 00038.01%-2.12M63.63%-683.75K81.77%-139.52K-1,527.72%-790.53K39.04%-506.23K7.24%-3.42M-637.75%-1.88M
Net PPE purchase and sale --0--0--0-39.09%-336.03K78.06%-11.25K22.04%-97.65K-2.83%-48.71K-909.15%-178.42K5.19%-241.58K79.88%-51.28K
Net intangibles purchas and sale --0--0--057.23%-818.5K98.71%-19.5K---41.87K---741.82K96.15%-15.31K---1.91M---1.52M
Net business purchase and sale --0--0--023.67%-965.5K-108.96%-653K100.00%1100.00%-1---312.5K63.14%-1.26M---312.5K
Cash from discontinued investing activities
Investing cash flow --0--0--038.01%-2.12M63.63%-683.75K81.77%-139.52K-1,527.72%-790.53K39.04%-506.23K7.24%-3.42M-637.75%-1.88M
Financing cash flow
Cash flow from continuing financing activities -1,515.74%-378.47K-100.07%-18.18K-59.27%1.18M26.62%29.78M026.73K166.99%26.87M-78.54%2.89M204.34%23.52M0
Net issuance payments of debt ---378.47K-1,594.10%-498.13K-159.48%-574.93K--1M--0--0--33.34K--966.66K--------
Net common stock issuance --0--013.00%2.13M6.72%26.31M--1.88M--0146.31%22.54M-87.84%1.88M196.59%24.65M--0
Proceeds from stock option exercised by employees --0-92.82%500K--0114.97%5.14M---1.88M--26.73K199.59%6.97M-46.47%36.4K697.48%2.39M--0
Net other financing activities --099.25%-20.05K---378.42K24.27%-2.67M--0--0-89.03%-2.67M-----298.97%-3.52M--0
Cash from discontinued financing activities
Financing cash flow -1,515.74%-378.47K-100.07%-18.18K-59.27%1.18M26.62%29.78M--0--26.73K166.99%26.87M-78.54%2.89M141.77%23.52M--0
Net cash flow
Beginning cash position -89.31%1.74M256.92%3.67M95.38%4.89M22.72%2.5M-22.48%8.57M-1.71%16.24M-91.41%1.03M22.72%2.5M-85.00%2.04M98.50%11.06M
Current changes in cash 83.66%-1.25M-112.73%-1.94M17.47%-1.21M415.15%2.39M64.19%-3.69M-102.88%-7.66M234.26%15.21M-114.74%-1.47M104.10%463.01K-213.16%-10.29M
End cash Position -94.36%483.2K-89.31%1.74M256.92%3.67M95.38%4.89M95.38%4.89M-22.48%8.57M-1.71%16.24M-91.41%1.03M22.72%2.5M22.72%2.5M
Free cash from 88.64%-873.53K83.56%-1.92M40.92%-2.39M-21.29%-26.43M69.62%-3.03M-145.11%-7.69M-124.18%-11.66M-16.62%-4.05M-23.83%-21.79M-88.79%-9.98M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data